Zhejiang Hisun Pharmaceutical Co.,Ltd.
As of 18 November 2026, for the company name Zhejiang Hisun Pharmaceutical Co.,Ltd. as recorded, the chemical-drug catalogue lists 42 active records with this name as holder; 125 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
53 acceptance records as first applicant, grouped into 30 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
UP-818-CC注射液 · No verified English name 1 records · Latest accepted 2026/08/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2600303 | Supplement | 2026/08/13 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
AST-3424注射液 · No verified English name 2 records · Latest accepted 2026/07/16
Supplement · 2
Ruxolitinib Phosphate Tablets 3 records · Latest accepted 2026/04/21
Generic · 2Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600913 | Generic | 2026/04/21 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2501930 | Supplement | 2025/09/28 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHS2500753 | Generic | 2025/02/17 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
海博麦布氨氯地平阿托伐他汀钙片 · No verified English name 1 records · Latest accepted 2026/04/13
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600431 | New drug | 2026/04/13 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
Posaconazole Enteric-coated Tablets 3 records · Latest accepted 2026/03/12
Supplement · 2Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600500 | Supplement | 2026/03/12 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2501285 | Supplement | 2025/06/30 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHS2301062 | Generic | 2023/04/15 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
泊沙康唑注射液 · No verified English name 3 records · Latest accepted 2026/02/07
Supplement · 1Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600271 | Supplement | 2026/02/07 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHS2302492 | Generic | 2023/09/15 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHS2101677 | Generic | 2021/09/02 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
Finerenone Tablets 1 records · Latest accepted 2025/12/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504299 | Generic | 2025/12/17 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
Glucosamine Sulfate Capsules 1 records · Latest accepted 2025/11/05
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2502278 | Supplement | 2025/11/05 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
Micafungin Sodium for Injection 1 records · Latest accepted 2025/10/15
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2502025 | Supplement | 2025/10/15 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
Teicoplanin for Injection 2 records · Latest accepted 2025/10/11
Supplement · 2
Daptomycin for Injection 2 records · Latest accepted 2025/10/11
Supplement · 2
Letermovir Injection 1 records · Latest accepted 2025/08/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502904 | Generic | 2025/08/09 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
Bedaquiline Fumarate Tablets 1 records · Latest accepted 2025/07/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502543 | Generic | 2025/07/16 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
HS387片 · No verified English name 3 records · Latest accepted 2025/04/18
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2500402 | New drug | 2025/04/18 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| CXHL2500401 | New drug | 2025/04/18 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| CXHL2500400 | New drug | 2025/04/18 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
Letermovir Tablets 1 records · Latest accepted 2025/04/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501368 | Generic | 2025/04/09 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
Everolimus Tablets 2 records · Latest accepted 2025/03/06
Supplement · 1Generic · 1
海博麦布片 · No verified English name 2 records · Latest accepted 2025/01/10
Supplement · 2
Apalutamide Tablets 1 records · Latest accepted 2025/01/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500122 | Generic | 2025/01/08 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
Tacrolimus Capsules 2 records · Latest accepted 2024/12/06
Supplement · 2
丁二磺酸腺苷蛋氨酸肠溶片 · No verified English name 1 records · Latest accepted 2024/02/07
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450105 | Supplement | 2024/02/07 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
门冬胰岛素注射液 · No verified English name 2 records · Latest accepted 2023/09/16
Supplement · 2
Eltrombopag Olamine Tablets 1 records · Latest accepted 2023/06/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301717 | Generic | 2023/06/28 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
HS329片 · No verified English name 2 records · Latest accepted 2023/05/05
New drug · 2
HS336片 · No verified English name 2 records · Latest accepted 2023/03/15
New drug · 2
Cycloserine Capsules 1 records · Latest accepted 2023/01/06
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350025 | Supplement | 2023/01/06 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
法维拉韦片 · No verified English name 3 records · Latest accepted 2022/08/12
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201432 | Supplement | 2022/08/12 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2102427 | Supplement | 2021/12/23 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHB2100220 | Supplement | 2021/02/05 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
阿普米司特片 · No verified English name 3 records · Latest accepted 2022/05/27
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200788 | Generic | 2022/05/27 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHS2200787 | Generic | 2022/05/27 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| CYHS2200786 | Generic | 2022/05/27 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
HS269片 · No verified English name 3 records · Latest accepted 2021/04/23
New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2101071 | New drug | 2021/04/23 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| CXHL2101070 | New drug | 2021/04/23 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| CXHL2101069 | New drug | 2021/04/23 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
Acarbose Tablets 1 records · Latest accepted 2021/04/12
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2101074 | Supplement | 2021/04/12 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
Ademetionine 1,4 - Butanedisulfonate For Injection 1 records · Latest accepted 2021/02/06
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150098 | Supplement | 2021/02/06 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
Changes in the last 90 days
4 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Marketing application approved: 1 applicationNo longer listed under review: 2 applicationsSupplement delivery: 1 application
- 2026/11/18No longer listed under review
Teicoplanin for Injection
CYHB2501986
Fact date: 2026/11/18 · Date added to this site: 2026/11/18
Accepted: 2025/10/11
no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/11/17 (approval no.: —; approval date: 2026/11/16); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 9
NMPA · Table row 9 ↗ View source ↗ - 2026/11/18Marketing application approved
Bedaquiline Fumarate Tablets
CYHS2502543 · 国药准字H20266638
Fact date: 2026/11/18 · Publication date: 2026/11/19 · Date added to this site: 2026/11/19
View source · Table row 66 ↗ - 2026/11/16Supplement delivery
Teicoplanin for Injection
CYHB2501986
Fact date: 2026/11/16 · Publication date: 2026/11/17 · Date added to this site: 2026/11/17
Supplemental application; excluded from new marketing approvals.
View source · Table row 9 ↗ - 2026/11/04No longer listed under review
Bedaquiline Fumarate Tablets
CYHS2502543
Fact date: 2026/11/04 · Date added to this site: 2026/11/04
Accepted: 2025/07/16
no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/11/19 (approval no.: 国药准字H20266638; approval date: 2026/11/18) · NMPA source · row 66
NMPA · Table row 66 ↗ View source ↗
Under review
3 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Ruxolitinib Phosphate Tablets | CYHS2600913 | Generic | 2026/04/21 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| Finerenone Tablets | CYHS2504299 | Generic | 2025/12/17 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| Letermovir Injection | CYHS2502904 | Generic | 2025/08/09 | Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
Catalogue holder records
42 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Letermovir Tablets | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20265140 | 2026/07/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Apalutamide Tablets | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20264460 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Everolimus Tablets | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20258293 | 2025/12/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tacrolimus Capsules | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20083039 | 2025/09/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tacrolimus Capsules | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20084386 | 2025/09/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 丁二磺酸腺苷蛋氨酸肠溶片 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20133197 | 2025/04/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 泊沙康唑注射液 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20253842 | 2025/04/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Everolimus Tablets | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20253002 | 2025/01/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Posaconazole Enteric-coated Tablets | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20244926 | 2024/09/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Eltrombopag Olamine Tablets | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20244679 | 2024/08/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Teicoplanin for Injection | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20093651 | 2024/07/08 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cycloserine Capsules | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20130063 | 2024/01/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 阿普米司特片 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20234153 | 2023/09/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 阿普米司特片 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20234155 | 2023/09/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 阿普米司特片 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20234154 | 2023/09/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Daptomycin for Injection | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20153259 | 2022/09/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ademetionine 1,4 - Butanedisulfonate For Injection | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20103110 | 2022/06/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Acarbose Tablets | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20227010 | 2022/01/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 法维拉韦片 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20203029 | 2021/11/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Vancomycin Hydrochloride for Injection | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20084268 | 2021/11/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Valsartan Film-Coated Tablets | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20213635 | 2021/08/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 注射用紫杉醇(白蛋白结合型) · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20213539 | 2021/06/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Micafungin Sodium for Injection | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20183082 | 2021/06/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Linezolid Tablets | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20213427 | 2021/06/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lurasidone Hydrochloride Tablets | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20213320 | 2021/04/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tofacitinib Citrate Tablets | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20213263 | 2021/04/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tigecycline for Injection | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20123339 | 2021/03/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Epirubicin Hydrochloride for Injection | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20183145 | 2021/03/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Apixaban Tablets | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20213173 | 2021/03/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 比卡鲁胺片 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20073877 | 2021/02/27 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Atorvastatin Calcium Tablets | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20213110 | 2021/02/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Atorvastatin Calcium Tablets | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20213109 | 2021/02/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Gemcitabine Hydrochloride for Injection | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20093417 | 2021/01/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Parecoxib Sodium for Injection | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20183463 | 2020/12/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ticagrelor Tablets | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20203436 | 2020/08/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ticagrelor Tablets | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20203435 | 2020/08/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Acarbose Tablets | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20203311 | 2020/07/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 盐酸多奈哌齐口崩片 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20203232 | 2020/06/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 盐酸多奈哌齐口崩片 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20203231 | 2020/06/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Letrozole Tablets | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20133109 | 2019/10/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Anastrozole Tablets | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20133110 | 2019/10/28 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Solifenacin Succinate Tablets | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Zhejiang Hisun Pharmaceutical Co.,Ltd. | 国药准字H20193202 | 2019/07/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
125 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 阿帕他胺 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20260000070 | I | 2026/02/26 | CDE ↗ |
| 来特莫韦 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20240001247 | A | 2026/06/29 | CDE ↗ |
| 非奈利酮 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20240001229 | A | 2026/09/17 | CDE ↗ |
| 富马酸贝达喹啉 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20230001222 | A | 2026/08/18 | CDE ↗ |
| 艾曲泊帕乙醇胺 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20230000251 | A | 2024/08/05 | CDE ↗ |
| 替格瑞洛 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20220000387 | A | 2023/05/30 | CDE ↗ |
| 阿糖胞苷 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20220000252 | A | 2024/09/15 | CDE ↗ |
| 海博麦布 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20200001538 | A | 2025/12/24 | CDE ↗ |
| 泊沙康唑 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20200001040 | A | 2026/11/03 | CDE ↗ |
| HS236 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190021530 | I | 2020/01/16 | CDE ↗ |
| 法维拉韦 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20200000119 | A | 2025/03/01 | CDE ↗ |
| 替加环素 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190009823 | A | — | CDE ↗ |
| 硫酸氨基葡萄糖氯化钠复盐 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190008580 | A | 2024/09/05 | CDE ↗ |
| 阿卡波糖 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190008441 | A | 2024/08/02 | CDE ↗ |
| 兰索拉唑 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190008201 | A | 2025/07/04 | CDE ↗ |
| 氯雷他定 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190007818 | A | — | CDE ↗ |
| 紫杉醇 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190007813 | A | 2024/10/16 | CDE ↗ |
| 氟氯西林钠 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190007723 | A | — | CDE ↗ |
| 瑞舒伐他汀钙 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190007514 | A | 2023/11/29 | CDE ↗ |
| 替考拉宁 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190007431 | A | 2024/06/17 | CDE ↗ |
| 奥沙利铂 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190007430 | A | 2023/09/09 | CDE ↗ |
| 阿那曲唑 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190007429 | A | 2024/11/19 | CDE ↗ |
| 盐酸吉西他滨 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190007428 | A | 2023/09/09 | CDE ↗ |
| 来曲唑 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190007336 | A | 2026/05/20 | CDE ↗ |
| 环磷酰胺 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190007332 | A | 2023/05/25 | CDE ↗ |
| 多西他赛 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190007331 | A | 2023/05/25 | CDE ↗ |
| 环丝氨酸 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190007223 | A | 2023/03/24 | CDE ↗ |
| 盐酸罗格列酮 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190007127 | A | 2023/03/24 | CDE ↗ |
| 异环磷酰胺 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190007096 | A | 2024/07/23 | CDE ↗ |
| 比卡鲁胺 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190007057 | A | 2026/08/26 | CDE ↗ |
| 伏格列波糖 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190007056 | A | 2023/03/24 | CDE ↗ |
| 酒石酸长春瑞滨 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190007054 | A | 2024/08/16 | CDE ↗ |
| 亚胺培南 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190006676 | A | 2026/01/13 | CDE ↗ |
| 西司他丁钠 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190006675 | A | 2026/01/27 | CDE ↗ |
| 谷胱甘肽 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190006655 | A | 2026/01/27 | CDE ↗ |
| 盐酸文拉法辛 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190006442 | A | 2025/01/15 | CDE ↗ |
| 帕米膦酸二钠 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190006400 | A | 2025/07/04 | CDE ↗ |
| 他唑巴坦 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190006391 | A | 2025/07/04 | CDE ↗ |
| 盐酸普罗帕酮 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190006366 | A | 2024/10/16 | CDE ↗ |
| 盐酸万古霉素 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190006263 | A | 2025/07/04 | CDE ↗ |
| 氟马西尼 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190005603 | A | 2024/10/16 | CDE ↗ |
| 吡喹酮 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190005423 | A | 2024/10/16 | CDE ↗ |
| 盐酸特比萘芬 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190004323 | A | 2024/08/15 | CDE ↗ |
| 盐酸大观霉素 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190004321 | A | — | CDE ↗ |
| 阿托伐他汀钙 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190004264 | A | 2025/03/18 | CDE ↗ |
| 伊维菌素 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190004252 | A | 2025/11/18 | CDE ↗ |
| 妥布霉素 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003640 | A | 2024/10/16 | CDE ↗ |
| 放线菌素D · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003593 | A | 2025/01/09 | CDE ↗ |
| 吡柔比星 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003580 | A | 2025/01/09 | CDE ↗ |
| 盐酸洛美沙星 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003578 | A | 2025/04/11 | CDE ↗ |
| 氟伐他汀钠 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003577 | A | 2025/02/28 | CDE ↗ |
| 丝裂霉素 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003568 | A | 2024/09/15 | CDE ↗ |
| 丁二酸洛沙平 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003552 | A | 2025/01/09 | CDE ↗ |
| 盐酸多柔比星 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003546 | A | 2025/01/09 | CDE ↗ |
| 盐酸表柔比星 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003545 | A | 2025/02/28 | CDE ↗ |
| 盐酸格拉司琼 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003542 | A | 2025/01/08 | CDE ↗ |
| 硝苯地平 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003540 | A | — | CDE ↗ |
| 去氧氟尿苷 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003534 | A | — | CDE ↗ |
| 磷酸腺嘌呤 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003528 | A | 2025/07/04 | CDE ↗ |
| 依替膦酸二钠 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003522 | A | 2024/08/31 | CDE ↗ |
| 厄贝沙坦 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003521 | A | 2024/07/23 | CDE ↗ |
| 氟脲苷 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003513 | A | 2024/10/22 | CDE ↗ |
| 硫酸异帕米星 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003511 | A | 2024/09/05 | CDE ↗ |
| 盐酸平阳霉素 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003508 | A | 2024/08/27 | CDE ↗ |
| 美罗培南 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003506 | A | 2024/09/12 | CDE ↗ |
| 氢溴酸西酞普兰 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003475 | A | 2024/10/16 | CDE ↗ |
| 克念菌素 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003471 | A | 2024/08/07 | CDE ↗ |
| 单硝酸异山梨酯 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003467 | A | 2024/08/27 | CDE ↗ |
| 头孢氨苄 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003465 | A | — | CDE ↗ |
| 司帕沙星 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003458 | A | 2025/07/04 | CDE ↗ |
| 阿莫西林 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003432 | A | — | CDE ↗ |
| 诺氟沙星 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190003422 | A | 2024/10/16 | CDE ↗ |
| 羟喜树碱 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002835 | A | 2024/10/24 | CDE ↗ |
| 奥氮平 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002833 | A | 2025/01/04 | CDE ↗ |
| 克拉屈滨 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002811 | A | 2024/08/02 | CDE ↗ |
| 氨曲南 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002808 | A | 2024/08/02 | CDE ↗ |
| 甲苯磺酸托氟沙星 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002527 | A | 2024/07/31 | CDE ↗ |
| 盐酸伊达比星 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002526 | A | 2024/08/02 | CDE ↗ |
| 头孢克肟 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002522 | A | — | CDE ↗ |
| 依诺沙星 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002486 | A | 2024/08/02 | CDE ↗ |
| 泛昔洛韦 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002471 | A | 2024/07/23 | CDE ↗ |
| 洛伐他汀 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002469 | A | 2024/08/02 | CDE ↗ |
| 辛伐他汀 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002466 | A | 2024/08/02 | CDE ↗ |
| 樟脑 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002407 | A | — | CDE ↗ |
| 齐多夫定 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002394 | A | — | CDE ↗ |
| 盐酸塞利洛尔 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002389 | A | 2024/10/24 | CDE ↗ |
| 普伐他汀钠 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002388 | A | 2024/08/02 | CDE ↗ |
| 酒石酸托特罗定 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002382 | A | 2024/08/31 | CDE ↗ |
| 盐酸环丙沙星 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002378 | A | 2024/10/16 | CDE ↗ |
| 头孢曲松钠 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002376 | A | — | CDE ↗ |
| 舒巴坦钠 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002370 | A | — | CDE ↗ |
| 哌拉西林 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002369 | A | 2024/08/07 | CDE ↗ |
| 哌拉西林钠 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002368 | A | 2024/08/28 | CDE ↗ |
| 佐米曲普坦 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002365 | A | — | CDE ↗ |
| 盐酸柔红霉素 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190002364 | A | 2024/08/07 | CDE ↗ |
| 盐酸舍曲林 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190001867 | A | 2024/10/16 | CDE ↗ |
| 盐酸博来霉素 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190001866 | A | 2024/08/08 | CDE ↗ |
| 盐酸阿糖胞苷 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190001759 | A | 2024/08/02 | CDE ↗ |
| 甲氨蝶呤 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190001758 | A | 2024/08/02 | CDE ↗ |
| 磷酸氟达拉滨 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190001757 | A | 2024/08/08 | CDE ↗ |
| 硫酸卷曲霉素 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190001756 | A | 2024/10/31 | CDE ↗ |
| 硫酸长春新碱 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190001747 | A | 2024/08/27 | CDE ↗ |
| 卡铂 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190001703 | A | 2024/10/31 | CDE ↗ |
| 丁二磺酸腺苷蛋氨酸 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190001701 | A | 2024/12/30 | CDE ↗ |
| 盐酸头孢吡肟 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190001325 | A | — | CDE ↗ |
| HS234 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190000933 | I | 2019/10/25 | CDE ↗ |
| 琥珀酸索利那新 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20180001761 | A | 2024/01/27 | CDE ↗ |
| 利奈唑胺 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190000342 | A | 2025/09/13 | CDE ↗ |
| 阿哌沙班 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20190000042 | A | 2025/12/11 | CDE ↗ |
| 枸橼酸托法替布 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20180001611 | A | 2025/09/13 | CDE ↗ |
| 利奈唑胺 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20180000772 | I | — | CDE ↗ |
| 替加环素 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20170002233 | A | 2022/10/12 | CDE ↗ |
| 盐酸莫西沙星 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20170001678 | A | 2025/12/27 | CDE ↗ |
| 达沙替尼 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20170001285 | A | 2023/05/25 | CDE ↗ |
| 阿立哌唑 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20170001236 | A | 2023/04/27 | CDE ↗ |
| 硫酸卡那霉素 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20170001095 | A | 2024/05/16 | CDE ↗ |
| 富马酸喹硫平 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20170001035 | A | 2023/05/09 | CDE ↗ |
| 帕瑞昔布钠 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20170000969 | A | 2024/02/28 | CDE ↗ |
| 氯沙坦钾 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20170000728 | I | — | CDE ↗ |
| 米卡芬净钠 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20170000533 | A | 2023/03/24 | CDE ↗ |
| 盐酸多奈哌齐 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20170000486 | A | 2023/04/25 | CDE ↗ |
| 盐酸伊立替康 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20170000354 | A | 2024/08/02 | CDE ↗ |
| 塞来昔布 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20170000353 | A | 2024/09/12 | CDE ↗ |
| 缬沙坦 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20170000289 | A | 2024/03/13 | CDE ↗ |
| 甲磺酸贝舒地尔 · No verified English name | Zhejiang Hisun Pharmaceutical Co.,Ltd. | Y20260000914 | I | 2026/11/03 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
22 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Rosuvastatin Calcium Tablets | CYHB2602062 | Supplement | 2026/11/13 | Han Hui Pharmaceutical Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| Rosuvastatin Calcium Tablets | CYHB2602061 | Supplement | 2026/11/13 | Han Hui Pharmaceutical Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| 眼用丝裂霉素溶液用粉末 · No verified English name | CYHS2601638 | Generic | 2026/07/08 | Han Hui Pharmaceutical Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| 注射用甲苯磺酸奥马环素 · No verified English name | CYHB2502075 | Supplement | 2025/10/17 | Zai Ding Pharmaceuticals (Shanghai) Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| 注射用甲苯磺酸奥马环素 · No verified English name | CYHB2501968 | Supplement | 2025/10/10 | Zai Ding Pharmaceuticals (Shanghai) Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| 海博麦布阿托伐他汀钙片 · No verified English name | CXHS2500013 | New drug | 2025/01/23 | Han Hui Pharmaceutical Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| 海博麦布阿托伐他汀钙片 · No verified English name | CXHS2500012 | New drug | 2025/01/23 | Han Hui Pharmaceutical Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| 盐酸伊立替康脂质体注射液 · No verified English name | CYHS2403130 | Generic | 2024/09/20 | Zhejiang Sheng Zhao Drug Technology Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| 眼用丝裂霉素溶液用粉末 · No verified English name | CYHS2401210 | Generic | 2024/04/23 | Zhejiang Zhang Dian Drug Technology Kai Fa Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| Rosuvastatin Calcium Tablets | CYHB2400488 | Supplement | 2024/04/11 | Han Hui Pharmaceutical Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| Rosuvastatin Calcium Tablets | CYHB2400487 | Supplement | 2024/04/11 | Han Hui Pharmaceutical Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| Tofacitinib Citrate Tablets | CYHB2301209 | Supplement | 2023/05/25 | Hai Zheng Biopharmaceutical Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| 注射用甲苯磺酸奥马环素 · No verified English name | CYHB2200884 | Supplement | 2022/06/02 | Zai Ding Pharmaceuticals (Shanghai) Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| Doxorubicin Hydrochloride Liposome Injection | CYHS2200689 | Generic | 2022/04/29 | Zhejiang Sheng Zhao Drug Technology Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| 大山楂咀嚼片 · No verified English name | CYZB2101956 | Supplement | 2021/11/16 | Zhejiang Zan Sheng Pharma Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| 心脑欣片 · No verified English name | CYZB2101955 | Supplement | 2021/11/16 | Zhejiang Zan Sheng Pharma Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| 通络生骨胶囊 · No verified English name | CYZB2101930 | Supplement | 2021/11/08 | Zhejiang Zan Sheng Pharma Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| 小柴胡胶囊 · No verified English name | CYZB2101929 | Supplement | 2021/11/08 | Zhejiang Zan Sheng Pharma Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| 香归逍遥颗粒 · No verified English name | CYZB2101927 | Supplement | 2021/11/08 | Zhejiang Zan Sheng Pharma Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| 香通片 · No verified English name | CYZB2101926 | Supplement | 2021/11/08 | Zhejiang Zan Sheng Pharma Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| Tofacitinib Citrate Tablets | CYHB2101629 | Supplement | 2021/07/26 | Hai Zheng Biopharmaceutical Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
| Mycophenolate Mofetil Capsules | CYHB2100239 | Supplement | 2021/02/09 | Zhejiang Zhang Dian Drug Technology Kai Fa Co., Ltd. romanized; Zhejiang Hisun Pharmaceutical Co.,Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.